Axsome Therapeutics, Inc. Annual Amortization of Intangible Assets in USD from 2022 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Axsome Therapeutics, Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from 2022 to 2023.
  • Axsome Therapeutics, Inc. Amortization of Intangible Assets for the quarter ending June 30, 2024 was $1.59M, a 0.06% increase year-over-year.
  • Axsome Therapeutics, Inc. Amortization of Intangible Assets for the twelve months ending June 30, 2024 was $6.39M.
  • Axsome Therapeutics, Inc. annual Amortization of Intangible Assets for 2023 was $6.38M, a 54% increase from 2022.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Annual (USD)
Amortization of Intangible Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $6.38M +$2.24M +54% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-23
2022 $4.14M Jan 1, 2022 Dec 31, 2022 10-K 2024-02-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.